The fungal secondary metabolite alternariol and Alternaria induced immunity (MPF6P.659)

Abstract

Sensitivity to the airborne fungus Alternaria alternata (common mold) is believed to be a common cause of allergic asthma. Epidemiological studies worldwide indicate that Alternaria sensitivity is closely linked with the development and exacerbation of allergic airway disorders such as asthma, allergic rhinitis, and chronic rhinosinusitis. Therapies are limited by the lack of knowledge about the role of individual fungal gene products in airway responses. The A. alternata mycotoxin alternariol is a genotoxic and cytotoxic molecule and a major contaminant of most food, grains and feed products. We hereby present a study where we explored the hypothesis of alternariol having immune-modulatory properties. It led us to the discovery that alternariol is strongly anti-inflammatory. We have investigated alternariol’s dynamic interplay between innate immunity and human bronchoalveolar epithelial cells. Immune assays have provided the key doses needed to suppress LPS-induced inflammation. We have also profiled the response of mutant fungal spores that no longer produce alternariol with normal wildtype spores on lung epithelium. This model has also been used to investigate alternariol’s mechanism of action in relation to aryl hydrocarbon receptor. Greater understanding of the role of alternariol in allergic asthma may lead to improved treatment strategies as well as a potential drug target for inflammatory syndromes.

Alternaria Infections in Immune-Compromised and Transplant Patients: A Review of Case Studies and Treatment Methods

“…[22] A record of opportunistic infections caused by Alternaria species is given in Table 2. [27,28] A. alternata…”